Michelle Bell

With its lead CAR-T therapy, Descartes-08, in late-stage trials, Cartesian Therapeutics is set to update investors on its pioneering work in autoimmune disease.

Maestro Tan Dun leads a unique music festival in a protected bay, blending world-class art with a bold conservation message for a global audience.

Industry veteran Patrick Söderlund takes the helm as Nexon's Executive Chairman, signaling a major strategic pivot toward Western markets and creative renewal.

After 11 years, Tucker Donahue is GFG Capital's new CIO, a move signaling strategic continuity and a deeper commitment to client engagement.

With 30 years of expertise, BRUCE Piling Equipment is meeting global demand with a new framework for site-specific deep foundation machinery.

As Ranger Energy Services prepares to release its Q4 results, investors are watching closely after a tough Q3. Will the report signal recovery or continued pain?

Cannabis giant Green Thumb Industries expands its credit facility to $189M, signaling strong lender confidence and fueling its strategic growth ambitions.

After 65 years, Generac is a finalist for Wisconsin's top manufacturing award, lauded for its tech innovation, economic impact, and community investment.

The Collegiate Cup is set as 12 universities head to Florida for the national championship, showcasing future stars and the rapid growth of cricket in America.

The suburban office REIT has extended key debt maturities and lowered borrowing costs, signaling lender confidence and positioning it for strategic growth.

Alta is set to reveal its full-year 2025 results after a year of strategic pivots. Investors will watch for signs of recovery and strategic progress.

vivo's new V70 challenges the premium market with a powerful ZEISS telephoto lens, a massive battery, robust IP69 rating, and a long-term software promise.

After a major pipeline pivot, Keros Therapeutics faces investors with a new lead drug, a fortified balance sheet, and a high-stakes strategy to prove.

With $3.7M in new capital, Sift Biosciences is developing a novel immunotherapy to awaken the body's memory T cells against hard-to-treat diseases.

Canary Capital's SUIS fund on Nasdaq offers investors SUI exposure plus staking rewards, entering a market with immediate competition and notable risks.

A major refinancing deal in Florida and Texas signals a Wall Street rush into senior living, a sector fueled by an aging population and tight supply.

Universal Health Services will present at three key March conferences, facing investors with robust profits but also cautious analyst outlooks and industry challenges.

USANA posts higher 2025 sales fueled by its Hiya and Rise brands, but a Q4 loss and a shrinking core business reveal the high cost of its transformation.

SRTX Inc., maker of 'unbreakable' Sheertex hosiery, files for creditor protection and sells assets to a rival. Can the innovative brand survive?

A new report reveals a major shift in digital strategy. Businesses are now betting big on AI to boost internal productivity, even as costs and complexity soar.